Skip to main content

Search
Profile

Bryan H. King, MD

|
Bryan H. King, MD

Psychiatry and Behavioral Health, Autism Center

On staff since September 2005

Children's Title: Director, Psychiatry and Behavioral Medicine; Program Director, Seattle Children's Autism Center

Research Center: Center for Child Health, Behavior and Development

Recommendations

CrystalLittleton NH09.16.11
I miss Dr. King so much. He was Jacy's doctor from the time he was 5 til he was 10 and there has never been anyone else like him. I wish he had been here a couple years ago so I could have brought my son to him for the most difficult situations I have ever had and I thought it was bad when he was younger I had no clue. Miss you Bryan lots. Crystal and Jacy McAlpin
AmyQuincy, CA07.30.11
Five years ago, our then 6 year old son experienced a horrifying and acute developmental regression. While other specialists (about 40 in total) were mystified by the disorder and offered little in answers, hope or treatment, Dr. King was open-minded and willing to examine our son's situation holistically. After detoxing him from previously prescribed meds that were not helping, he tried a med that he had been researching and led a team of specialists to address all of our son's needs, including education, speech, behavioral, and ocupational therapy. I'm happy to report that five years and countless hours of work later, our son is on a remarkable path to recovery and a fulfilling life. Before we came to Dr. King we were almost out of options and hope for our son, Dr. King's compassion and innovation to try something different literally saved our son.
Recommend Dr. Bryan King

Overview

Board Certification(s)
Child and Adolescent Psychiatry
Psychiatry
Medical/Professional School
Medical College of Wisconsin, Milwaukee
Residency
Psychiatry, UCLA Neuropsychiatric Hospital, Los Angeles
Fellowship
Child and Adolescent Psychiatry, UCLA Neuropsychiatric Hospital, Los Angeles
Clinical Interests

Autism, Developmental Disabilities, Child and Adolescent Psychiatry

Research Focus Area

Behavioral / Mental Health

Awards and Honors

Award NameAward DescriptionAwarded ByAward Date
U.S. News Top DoctorU.S. News and World Report 2012
Seattle Magazine Top Doctor - 2011Seattle Magazine Top Doctor - 2011Seattle Magazine 2011

Publications

Commentary from the DSM-5 Workgroup on Neurodevelopmental Disorders.
Journal of the American Academy of Child and Adolescent Psychiatry , 2012 Apr: 51(4)347-9
Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders.
Journal of autism and developmental disorders , 2012 Mar: 42(3)432-40
Consensus Paper: Pathological Role of the Cerebellum in Autism.
Cerebellum (London, England) , 2012 Feb 28
Understanding the origins of time-dependent inhibition by polypeptide deformylase inhibitors.
Biochemistry , 2011 Aug 9: 50(31)6642-54
Is schizophrenia on the autism spectrum?
Brain research , 2011 Mar 22: 138034-41
The association between short and long nocturnal sleep durations and risky behaviours and the moderating factors in Taiwanese adolescents.
Psychiatry research , 2010 Aug 30: 179(1)69-74
The association between short and long nocturnal sleep durations and risky behaviours and the moderating factors in Taiwanese adolescents.
Psychiatry research , 2010 Aug 30: 69-74
Factor structure of the Athens Insomnia Scale and its associations with demographic characteristics and depression in adolescents.
Journal of sleep research , 2010 Mar: 19(1 Pt 1)12-8
Factor structure of the Athens Insomnia Scale and its associations with demographic characteristics and depression in adolescents.
Journal of sleep research , 2010 Mar: 12-8
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
Archives of general psychiatry , 2009 Jun: 66(6)583-90
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
Archives of general psychiatry , 2009 Jun: 583-90
Pharmacology and genetics of autism: implications for diagnosis and treatment.
Personalized medicine , 2008 Nov: 5(6)599-607
Pharmacology and genetics of autism: implications for diagnosis and treatment.
Personalized medicine , 2008 Nov: 599-607
Asperger's syndrome: diagnosis and treatment.
The American journal of psychiatry , 2008 Aug: 165(8)958-63
Asperger's syndrome: diagnosis and treatment.
The American journal of psychiatry , 2008 Aug: 958-63
Forces shaping the fastest evolving regions in the human genome.
PLoS genetics , 2006 Oct 13: 2(10)e168
An RNA gene expressed during cortical development evolved rapidly in humans.
Nature , 2006 Sep 14: 443(7108)167-72
An update on pharmacologic treatments for autism spectrum disorders.
Child and adolescent psychiatric clinics of North America , 2006 Jan: 15(1)161-75
An update on pharmacologic treatments for autism spectrum disorders.
Child and adolescent psychiatric clinics of North America , 2006 Jan: 161-75
Autism spectrum disorders: emerging pharmacotherapy.
Expert opinion on emerging drugs , 2005 Aug: 10(3)521-36
Autism spectrum disorders: emerging pharmacotherapy.
Expert opinion on emerging drugs , 2005 Aug: 521-36
Outcome measures for clinical drug trials in autism.
CNS spectrums , 2004 Jan: 9(1)36-47
Impact of recent findings on study design of future autism clinical trials.
CNS spectrums , 2004 Jan: 9(1)49-56
Outcome measures for clinical drug trials in autism.
CNS spectrums , 2004 Jan: 36-47
Impact of recent findings on study design of future autism clinical trials.
CNS spectrums , 2004 Jan: 49-56
Asperger syndrome: to be or not to be?
Current opinion in pediatrics , 2003 Oct: 15(5)491-4
Asperger syndrome: to be or not to be?
Current opinion in pediatrics , 2003 Oct: 491-4
The quality of health care for adults with developmental disabilities.
Public health reports (Washington, D.C. : 1974) , 2002 Mar-Apr: 117(2)174-84
The quality of health care for adults with developmental disabilities.
Public health reports (Washington, D.C. : 1974) , 2002 Mar-Apr: 174-84

Presentations

Presentations TitleEventLocationDate
Master Clinician, Bryan H. King, MD56th Annual meeting of the American Academy of Child and Adolescent PsychiatryHonolulu, HINov. 1, 2009
A comprehensive approach to psychopharmacology in intellectual disabilities56th Annual meeting of the American Academy of Child and Adolescent PsychiatryHonolulu, HINov. 1, 2009
Autism Yesterday, Today, and TomorrowFirst Annual TESSERA ConferenceBellevue, WANov. 1, 2009
Appropriate medication use in autismThe HELP Group Summit 2009Los Angeles, CANov. 1, 2009
Autism Past, Present, and FutureThe HELP Group Summit 2009Los Angeles, CANov. 1, 2009
Pharmacotherapy in Autism: Time for an UpdateGrand Rounds Presentation, University of MassachusettsWorchester, MAJune 1, 2009
Psychopharmacologic Treatment in Intellectual Disability. Keynote PresentationBuilding Solutions through Community Collaboration: Enhancing Services for Individuals who are Dually Served. Conference sponsored by California State Department of Developmental Services and the San Diego Regional CenterOntario, CAMarch 1, 2009

Research Funding

Grant TitleGrantorAmountAward Date
EXTENDED MANAGEMENT AND MEASUREMENT OF AUTISMUNKNOWN $104,904.00Nov. 1, 2008
AUTISM INTERVENTION RESEARCH NETWORK—PHYSICAL (AIR-P)HRSA $242,466.00Oct. 1, 2008
AUTISM INTERVENTION RESEARCH NETWORK—BEHAVIOR (AIR-B)HRSA $700,768.00Oct. 1, 2008
AUTISM TREATMENT NETWORK REGISTRYUNIVERSITY OF WASHINGTON, AUTISM SPEAKS $479,000.00Jan. 1, 2008
A STUDY OF FLUOXETINE IN AUTISMAUTISM SPEAKS $132,092.00July 1, 2007
UW AUTISM CENTER OF EXCELLENCE (P50 HD055782)NICHD $9,330,000.00June 1, 2007

Primary Office

Seattle Children's
OA.5.154 - Child Psychiatry
4800 Sand Point Way NE
Seattle, WA 98105
206-987-2164

Find a Doctor or Researcher

Find a Doctor or Researcher

Type the first or last name you are searching for or select a specialty.

Doctor or Researcher Name:

More search options